Submissions

This letter sets forth the scientific and regulatory reasons that fluoride does not meet the Proposition 65 criteria for listing.

Comments submitted by the Consumer Healthcare Products Association and the Personal Care Products Council regarding draft guidance for industry on enforcement policy for OTC sunscreen drug products marketed without an approved application.

Personal Care Products Council and CHPA comments in response to FDA rule regarding labeling and effectiveness requirements for certain OTC sunscreen products.

CHPA applauds the approach for creating a public forum to collect current research and comments to advance the science of engineered nanomaterials.

CHPA recognizes the need for modernization of USP monographs. CHPA member companies are dedicated to fulfilling their commitment outlined in the letter to this Planning Committee on February 2, 2011.

CHPA strongly supports the unanimous votes by the advisory committees to add weight-based dosing directions to the existing age-based labeled dosing directions for children.

Briefing book for the Joint Meeting of the Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee, May 17-18, 2011.

Comments to the EPA addressing the recent petition from Food and Water Watch and Beyond Pesticides entitled "Citizen Petition for a Ban on Triclosan".

We encourage the FDA to continue to abide by its current guidance statement which indicates that there is no causal link between the intake of synthetic food colors and childhood hyperactivity.